Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05603468

Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair

Effect of Platelet-Rich Plasma vs Corticosteroid Injection in Distinct Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair: a Multicenter, Three-group, Randomized Controlled Trial

Status
Active Not Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
387 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Prospective, multicenter, randomized, single-blinded, parallel group,placebo-controlled,three-group establishment of specific treatment regimen for subtypes of tendinopathy

Detailed description

This clinical trial uses machine learning to match molecular and clinical features,so as to establish a "rapid recognition system of tendinopathy subtypes" and compares the clinical effects of corticosteroid,platelet rich plasma or placebo on different subtypes of tendinopathy.

Conditions

Interventions

TypeNameDescription
DRUGplatelet rich plasmaPlatelet rich plasma group: after the surgery of rotator arthroscopic rotator cuff repair, 3ml PRP (LongTai Biological Company) was injected into the rotator cuff tear under the rotator arthroscope for a time. PRP production process: before anesthesia, 20ml arterial blood was drawn and injected into the PRP tube. The blood was fully oscillated in the tube, and then placed in a centrifuge with 1500g for 9min to remove excess plasma and make 5ml PRP. 3ml is used for injection and 2ml is used for quality control.
DRUGCorticosteroidCorticosteroid group: after the surgery of rotator cuff repair under arthroscopy, 1mL prednisone (MSD) + 2mL sodium hyaluronate (biochemical Industry Co., Ltd.) was injected under arthroscopy.
DRUGNormal salineNormal saline

Timeline

Start date
2022-12-15
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2022-11-02
Last updated
2026-02-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05603468. Inclusion in this directory is not an endorsement.